Skip to main content
. 2019 Nov 1;20(21):5452. doi: 10.3390/ijms20215452
TILs Tumor-infiltrating lymphocytes
MHC Major histocompatibility complex
CTL Cytotoxic T lymphocytes
NK Natural killer
PD-1 Programmed cell death-protein 1
CRLA-4 CTL-associated protein 4
PD-L1 Programmed cell death-ligand 1
MMR Mismatch repair
IHC Immunohistochemistry
PCR Polymerase chain reaction
NGS Next-generation sequencing
TMB Tumor mutational burden
CD Companion diagnostic
MSI Microsatellite instability
NSCLC Non-small cell lung cancer
TPS Tumor proportion score
CPS Combined positive score
EGFR Epidermal growth factor receptor
TKIs Tyrosine kinase inhibitors
LAG-3 Lymphocyte activation gene-3
ECP Eosinophil cationic protein
CRC Colorectal cancer
MSI-H Microsatellite instability high
FDA Food and Drug Administration
GC Gastric cancer
OS Overall survival
DFS Disease-free survival
MSS Microsatellite stable
HNSCC Squamous-cell carcinoma of the head and neck
ORR Objective response rate
HPV Human papillomavirus
UC Urothelial carcinoma
POLE polymerase-ε
TCGA The Cancer Genome Atlas
TNBC Triple-negative breast cancer
ER Estrogen receptor